FYI: Science Policy News
FYI
/
Article

New Biotech Commission Issues Interim Report

JAN 16, 2024
The National Security Commission on Emerging Biotechnology published an interim report outlining recommendations for the U.S. to advance its domestic biotechnology industry.
lindsay-mckenzie-2.jpg
Science Policy Reporter, FYI AIP
biotechnology-commission-interim-report-cover-2023.png

Cover image for the interim report of the National Security Commission on Emerging Biotechnology

(NSCEB)

The National Security Commission on Emerging Biotechnology published an interim report last month, outlining its initial policy recommendations for the U.S. to advance its domestic biotechnology industry and use advances in biotechnology to boost national security and economic competitiveness.

The report warns that, without action, the U.S. will fall behind China in biotechnology. In addition to urging greater investment in biotechnology R&D, the commission proposes new legislation to improve coordination between the Department of Agriculture and national security agencies through the creation of a senior adviser for national security within the USDA. It also proposes the creation of an interagency Biotechnology Oversight Coordination Committee by the White House’s Office of Science and Technology Policy and Office of Management and Budget.

Congress chartered the commission, modeling it on the National Security Commission on AI. The 12-member commission is chaired by Ginkgo Bioworks CEO Jason Kelly and includes Sens. Alex Padilla (D-CA) and Todd Young (R-IN) and Reps. Stephanie Bice (R-OK) and Ro Khanna (D-CA). Also among the members is Eric Schmidt, who co-chaired the NSCAI.

Related Topics
More from FYI
FYI
/
Article
FYI
/
Article
FYI
/
Article
Ned Mamula and Andrea Travnicek set to return to USGS and the Department of the Interior.
FYI
/
Article
The Trump administration’s efforts to slash research overhead costs have been put on hold for now.
FYI
/
Article
Chris Wright’s first order calls for prioritizing “true technological breakthroughs.”
FYI
/
Article
The new House Science Committee chair called for reducing red tape in research and did not comment on the disruptions caused by Trump’s executive orders.

Related Organizations